<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04241328</url>
  </required_header>
  <id_info>
    <org_study_id>MDT19022PMF001</org_study_id>
    <nct_id>NCT04241328</nct_id>
  </id_info>
  <brief_title>Observational, Multi-center, Prospective Post-market Registry</brief_title>
  <acronym>SYMBIOSIS</acronym>
  <official_title>SYMBIOSIS Post-Market Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiovascular</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this observational, multi-center prospective, post-market registry is to&#xD;
      confirm real-world device safety and performance, to ensure the continued acceptability of&#xD;
      identified risks, and detect emerging risks.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective is to collect product safety and performance data for Medtronic CE (Conformitè&#xD;
      Europëenne )-Marked Coronary and Structural Heart (CSH) products.&#xD;
&#xD;
      The main goals of this data collection are as follows:&#xD;
&#xD;
        -  Identification of any (new) device-related complications including events which were not&#xD;
           anticipated or documented in the Instructions For Use (IFU), or Risk Management Plan, or&#xD;
           Clinical Evidence Evaluation report, or Design Failure Modes and Effect Analysis&#xD;
&#xD;
        -  Evaluation of device success defined as the absence of any device-related adverse events&#xD;
           or device deficiencies&#xD;
&#xD;
        -  Evaluation of general device performance when applicable&#xD;
&#xD;
      Subjects are enrolled and, if applicable, followed according to routine care practices at&#xD;
      their treating hospital.&#xD;
&#xD;
      Inclusion Criteria:&#xD;
&#xD;
        -  Subject or legally authorized representative provides written data release and/or&#xD;
           informed consent per institution and/or geographical requirements prior to discharge&#xD;
           from participating Registry hospital.&#xD;
&#xD;
        -  Subject will undergo or underwent a procedure in which an eligible Medtronic CSH product&#xD;
           is/was used.&#xD;
&#xD;
      Exclusion Criteria:&#xD;
&#xD;
      • Currently participating in an interventional drug or device study which may induce&#xD;
      confounding factor(s) to the results from this Registry&#xD;
&#xD;
      Data collection includes, for example:&#xD;
&#xD;
        -  Demographics&#xD;
&#xD;
        -  Product performance information&#xD;
&#xD;
        -  Safety Events&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 9, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Device Safety</measure>
    <time_frame>Procedural</time_frame>
    <description>Procedure- , device-related events and device deficiencies</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Device performance</measure>
    <time_frame>Procedural</time_frame>
    <description>Device Success</description>
  </primary_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All consecutive subjects with the intent of being treated or treated (up to discharge from&#xD;
        treating hospital) with a market-approved Medtronic CSH product, are candidates to be&#xD;
        enrolled. The Investigator will determine subject eligibility in SYMBIOSIS based upon the&#xD;
        inclusion/exclusion criteria. If a subject meets all inclusion and none of the exclusion&#xD;
        criteria, they will be informed about the SYMBIOSIS Registry. SYMBIOSIS will collect data&#xD;
        of numerous patient conditions for which Medtronic CSH products are being used.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject or legally authorized representative provides written data release and/or&#xD;
             informed consent per institution and/or geographical requirements prior to discharge&#xD;
             from participating registry hospital.&#xD;
&#xD;
          -  Subject will undergo or underwent a procedure in which an eligible Medtronic CSH&#xD;
             product is/was used.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Currently participating in an interventional drug or device study which may induce&#xD;
             confounding factor(s) to the results from this Registry&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lisa Lindelauf, BSc</last_name>
    <phone>+31611605434</phone>
    <email>lisa.lindelauf@medtronic.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>AKH Wien</name>
      <address>
        <city>Wien</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>D Wiedemann, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ziekenhuis Oost-Limburg</name>
      <address>
        <city>Genk</city>
        <zip>3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. Pettinari, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wouter Oosterlinck, Doctor</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU d'Angers</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe Baufreton, Professor</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Herz- und Diabeteszentrum NRW</name>
      <address>
        <city>Bad Oeynhausen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Gummert, Professor</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onassis Cardiac Surgery Center</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George Stavridis, Doctor</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Catharina Ziekenhuis</name>
      <address>
        <city>Eindhoven</city>
        <zip>5623 EJ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr. Bart Koene</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Antonius Ziekenhuis</name>
      <address>
        <city>Nieuwegein</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr. Patrick Klein</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Haukeland Universitetssjukehus</name>
      <address>
        <city>Bergen</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rune Haaverstad, Professor</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Netherlands</country>
    <country>Norway</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>January 22, 2020</study_first_submitted>
  <study_first_submitted_qc>January 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2020</study_first_posted>
  <last_update_submitted>October 29, 2021</last_update_submitted>
  <last_update_submitted_qc>October 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

